References
- GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1345–1422.
- Marczak L, Williams J, Loeffler M. For the Institute for Health Metrics and Evaluation. Global deaths attributable to high systolic blood pressure, 1990–2016. JAMA. 2018;319(21):2163.
- Reckelhoff JF. Gender differences in the regulation of blood pressure. Hypertension. 2001;37(5):1199–1208.
- Banegas JR, Segura J, de la Sierra A, et al. Gender differences in office and ambulatory control of hypertension. Am J Med. 2008;121(12):1078–1084.
- MacDonald K, Lee CS, Chen HC, et al. Gender-specific, multi-level determinants of outcomes of antihypertensive treatment: a sub-analysis of the Belgian PREVIEW Study. J Hum Hypertens. 2011;25(6):372–382.
- Daugherty SL, Masoudi FA, Ellis JL, et al. Age dependent gender differences in hypertension management. J Hypertens. 2011;29:1005–1011.
- Doumas M, Papademetriou V, Faselis C, et al. Gender differences in hypertension: myths and reality. Curr Hypertens Rep. 2013;15(4):321–330.
- Gillis EE, Sullivan JC. Sex differences in hypertension: recent advances. Hypertension. 2016;68(6):1322–1327.
- Abraham I, MacDonald K, Hermans C, et al. Real-world effectiveness of valsartan on hypertension and total cardiovascular risk: review and implications of a translational research program. Vasc Health Risk Manag. 2011;7:209–235.
- Van der Niepen P, Woestenburg A, Brié H, et al. Effectiveness of valsartan for treatment of hypertension: patient profiling and hierarchical modeling of determinants and outcomes (the PREVIEW study). Ann Pharmacother. 2009;43(5):849–861.
- Abraham I, Van Camp Y, Villa L, et al. Hierarchical modeling of patient and physician determinants of blood pressure outcomes in adherent vs nonadherent hypertensive patients: pooled analysis of 6 studies with 14,646 evaluable patients. J Clin Hypertens. 2013;15(9):663–673.
- Carey RM, Whelton PK. Evidence for the universal blood pressure goal of <130/80 mm Hg Is strong: controversies in hypertension – pro side of the argument. Hypertension. 2020;76(5):1384–1390.
- DiMatteo MR, Giordani PJ, Lepper HS, et al. Patient adherence and medical treatment outcomes – a meta-analysis. Med Care. 2002;40:757–764.
- Gouni-Berthold I, Berthold HK. Role of physician gender in drug therapy. Handb Exp Pharmacol. 2012;(214):183–208.